alexa Fingolimod to Treat Relapsing Multiple Sclerosis

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Fingolimod to Treat Relapsing Multiple Sclerosis

Symptoms or adverse events experienced by patients with multiple sclerosis (MS) can affect their health-related quality of life (QOL) and treatment satisfaction, and can be caused by either the disease itself or the disease-modifying therapy (DMT). The EPOC study assessed the effects of switching from an injectable disease-modifying therapy (glatiramer acetate or one of three interferon beta drugs) to once-daily, oral fingolimod 0.5 mg in patients with relapsing MS.

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger